Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CD133+ Cell Infusion for Colorectal Liver Metastases Prior to Resection
NCT03803241Phase 2Completed
- Sponsor
- Hospital Clínico San Carlos
- Start
- May 2019
- Primary completion
- Dec 2020
- Countries
- 1
01
Overview
Phase 2, randomised trial in Colorectal cancer with liver metastases (CRLM) (2 arms), sponsored by Hospital Clínico San Carlos. Primary endpoint: Liver volume. Started May 2019; status: completed.
02
Conditions
Colorectal cancer with liver metastases (CRLM)
Beyond the preview
Go deeper on NCT03803241.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03803241.